PT-141: Handling, Storage, and Reconstitution Guide

This PT-141 handling and storage guide covers laboratory best practices for working with the cyclic heptapeptide as a lyophilized research material. It addresses reconstitution for in vitro preparation, cold-chain storage, aliquoting, and documentation, all framed strictly as laboratory procedure.

PT-141 Handling and Storage Fundamentals

PT-141 ships as a solid, white lyophilized powder in a sealed glass vial. Store the lyophilized material at or below 25 degrees Celsius, sealed and protected from heat, light, and moisture. For extended storage, keep it lyophilized and refrigerated or frozen so that peptide integrity is preserved across the study period.

Consistent storage conditions are part of quality assurance, not an afterthought. Monitoring storage records and holding temperature and light exposure constant helps ensure that the material used in later experiments matches the identity documented at receipt. Because PT-141 is a melanocortin peptide handled alongside related compounds, the same cold-chain discipline used for the Melanotan 2 handling guide applies here.

Reconstitution for In Vitro Preparation

For in vitro work, PT-141 is reconstituted with bacteriostatic water added slowly down the vial wall, then swirled gently rather than shaken to avoid mechanical stress on the peptide. Working concentration should follow the assay design rather than a fixed formula, since binding and cAMP experiments call for different ranges.

Prepare under clean conditions with calibrated pipettes and appropriate PPE. This is reagent preparation for laboratory assays, not a route of administration, and none of the steps here describe human or veterinary use. Concentration choices tie back to the receptor systems and endpoints outlined in the PT-141 research applications.

Aliquoting and Freeze-Thaw Control

Dividing reconstituted material into single-use aliquots limits repeated freeze-thaw cycles, which can degrade peptides and introduce variability. Aliquoting is one of the simplest ways to protect the metabolic stability that makes PT-141 useful as a reference ligand in the first place.

Label each aliquot with compound name, concentration, lot number, and date, and log the storage location to keep the cold chain auditable. A clear aliquot record makes it straightforward to trace any assay back to the exact vial and preparation that produced it.

Material Identity and Specifications

Confirming identity before use anchors handling to the correct molecule. PT-141 (Bremelanotide) has the molecular formula C50H68N14O10, a molecular weight of approximately 1025.18 g/mol, CAS number 189691-06-3, and PubChem CID 9941379. Its full structure is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH.

Recording these identifiers alongside the lot number ties handling and storage decisions to a specific, verified batch. This is especially useful when the peptide is stored beside structurally similar melanocortin analogs, where mislabeling would otherwise be easy.

Documentation and COA Verification

Each PT-141 batch ships with a third-party-verified certificate of analysis documenting purity by HPLC or reverse-phase chromatography, mass-spectrometry identity confirmation, and lot number, testing date, and method details. Recording the lot number against results ties data to a specific batch and supports the reproducibility of the readouts described in the PT-141 mechanism of action.

Sample certificates of analysis can be requested before purchase, and material with documentation is available on the PT-141 product page. Teams handling related melanocortin peptides can cross-reference the pigmentation-focused material discussed for Melanotan 1 when standardizing storage across a panel.

Safety and Compliance

Handle PT-141 as a research chemical: qualified personnel only, work in controlled environments, use engineering controls where required, and follow institutional SOPs and chemical hygiene plans. Wear appropriate PPE including lab coat, gloves, and eye protection, and dispose of material per institutional and applicable regulations.

Retaining certificates of analysis and batch documentation, and maintaining consistent storage throughout the study period, supports traceability and audit readiness. Complete records are what let handling practice reinforce, rather than undermine, the quality of the underlying research data.

For research use only. PT-141 is an investigational research peptide and is not approved for human or veterinary use. All handling guidance refers to laboratory procedure only.